HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE - 3'-AZIDODEOXYTHYMIDINE 5'-TRIPHOSPHATE INHIBITION INDICATES 2-STEP BINDING FOR TEMPLATE-PRIMER

被引:25
作者
JAJU, M
BEARD, WA
WILSON, SH
机构
[1] UNIV TEXAS,MED BRANCH,SEALY CTR MOLEC SCI,GALVESTON,TX 77555
[2] NCI,BIOCHEM LAB,BETHESDA,MD 20892
关键词
D O I
10.1074/jbc.270.17.9740
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human immunodeficiency virus type-1 (HIV-1) reverse transcriptase (RT) catalyzes DNA synthesis by an ordered sequential mechanism, After template-primer (T . P) binds to free enzyme, the deoxynucleoside triphosphate to be incorporated binds to the RT and T . P binary complex (RT(T . P)). After incorporation of the bound nucleotide, catalytic cycling is limited either by a conformational change (for processive synthesis) or release of the enzyme from the extended T . P (for single-nucleotide incorporation), To explore cycling through these alternate rate-limiting steps, we determined kinetic parameters for single-nucleotide incorporation by HXB2R HIV-1 RT with chain-terminating nucleotide substrates 3'-azido-3'-deoxythymidine triphosphate (AZTTP) and dideoxythymidine triphosphate on a homopolymeric T . P system, poly(rA)-oligo(dT)(16). Inhibition of processive deoxythymidine monophosphate in corporation by these chain-terminating substrates was also examined Because AZTTP is a substrate, its K-m should be equivalent to K-i, and since K-m for AZTTP should be influenced by the dissociation rate constant for RT(T . P), we examined the effect of altering RT(T .) P dissociation on AZTTP kinetic parameters, The dissociation rate constant was modulated by making use of different T . P substrates, viral sources of RT, and a mutant RT altered at a residue that perturbs T . P binding, As expected from earlier work, the time course of AZTMP incorporation on poly(rA)-oligo(dT)(16) was biphasic, with a burst followed by a slower steady-state phase representing k(cat) (0.42 min(-1)) which was similar to the rate constant for RT(T . P) dissociation. Additionally, K-m for AZTTP (110 nM) was lower than its equilibrium dissociation constant (1200 nM). AZTTP inhibition (K-i,K-AZTTP) of processive dTMP incorporation and incorporation of a single nucleotide were similar, However, a simple correlation between the RT(T . P) dissociation rate constant and K-i,K-AZTTP was not observed, These results indicate that a simple ordered model for single-nucleotide incorporation is inadequate and that different forms of RT(T . P) exist which can limit catalysis, The results are discussed in the context of a two-step binding reaction for T . P where the binary RT(T . P) complex undergoes an isomerization before binding of the deoxynucleotide substrate.
引用
收藏
页码:9740 / 9747
页数:8
相关论文
共 30 条
[1]   KINETICS AND INTERMEDIATES IN INTRACELLULAR SYNTHESIS OF BACTERIOPHAGE T4 DEOXYRIBONUCLEIC ACID [J].
ALTMAN, S ;
LERMAN, LS .
JOURNAL OF MOLECULAR BIOLOGY, 1970, 50 (02) :235-&
[2]   ANALYSIS OF NUMERICAL-METHODS FOR COMPUTER-SIMULATION OF KINETIC PROCESSES - DEVELOPMENT OF KINSIM - A FLEXIBLE, PORTABLE SYSTEM [J].
BARSHOP, BA ;
WRENN, RF ;
FRIEDEN, C .
ANALYTICAL BIOCHEMISTRY, 1983, 130 (01) :134-145
[3]   IDENTIFICATION OF THE PRIMER BINDING DOMAIN IN HUMAN-IMMUNODEFICIENCY-VIRUS REVERSE-TRANSCRIPTASE [J].
BASU, A ;
AHLUWALIA, KK ;
BASU, S ;
MODAK, MJ .
BIOCHEMISTRY, 1992, 31 (02) :616-623
[4]   KINETIC-ANALYSIS OF TEMPLATE.PRIMER INTERACTIONS WITH RECOMBINANT FORMS OF HIV-1 REVERSE-TRANSCRIPTASE [J].
BEARD, WA ;
WILSON, SH .
BIOCHEMISTRY, 1993, 32 (37) :9745-9753
[5]  
BECERRA SP, 1991, BIOCHEMISTRY-US, V30, P11708
[6]   SENSITIVITY OF WILD-TYPE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE TO DIDEOXYNUCLEOTIDES DEPENDS ON TEMPLATE LENGTH - THE SENSITIVITY OF DRUG-RESISTANT MUTANTS DOES NOT [J].
BOYER, PL ;
TANTILLO, C ;
JACOBOMOLINA, A ;
NANNI, RG ;
DING, JP ;
ARNOLD, E ;
HUGHES, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (11) :4882-4886
[7]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[8]   KINETICS OF INTERACTION OF HIV REVERSE-TRANSCRIPTASE WITH PRIMER TEMPLATE [J].
DIVITA, G ;
MULLER, B ;
IMMENDORFER, U ;
GAUTEL, M ;
RITTINGER, K ;
RESTLE, T ;
GOODY, RS .
BIOCHEMISTRY, 1993, 32 (31) :7966-7971
[9]   STRUCTURE-FUNCTION STUDIES OF HIV-1(1) REVERSE-TRANSCRIPTASE - DIMERIZATION-DEFECTIVE MUTANT L289K [J].
GOEL, R ;
BEARD, WA ;
KUMAR, A ;
CASASFINET, JR ;
STRUB, MP ;
STAHL, SJ ;
LEWIS, MS ;
BEBENEK, K ;
BECERRA, SP ;
KUNKEL, TA ;
WILSON, SH .
BIOCHEMISTRY, 1993, 32 (48) :13012-13018
[10]   FACTORS CONTRIBUTING TO THE INHIBITION OF HIV REVERSE-TRANSCRIPTASE BY CHAIN-TERMINATING NUCLEOTIDES INVITRO AND INVIVO [J].
GOODY, RS ;
MULLER, B ;
RESTLE, T .
FEBS LETTERS, 1991, 291 (01) :1-5